Pregnancy News and Research

Latest Pregnancy News and Research

CP Family Network's guide helps parents find resouces for their children with Cerebral Palsy

What started with the frustration of three families in three different states to find resources for their children with Cerebral Palsy has turned into the CP Family Network's "Survival Guides" for all 50 states. The non-profit organization announced today the completion of the last guide.

26 Aug 2009

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

A chemical compound found in unpasteurised food has been detected in unusually high levels in the red blood cells of pregnant women with the condition pre-eclampsia.

26 Aug 2009

Garden Of Life introduces dietary supplement capsule that minimizes varicose and spider veins

For years, millions of women tried everything from heavy leg make up to dark pantyhose to cover up unsightly varicose and spider veins. Now there's a better way to reduce the appearance of unwanted veins with Garden of Life's (www.gardenoflife.com) Lovely Legs(TM), the only dietary supplement backed by extensive human clinical studies and millions of happy European women.

25 Aug 2009

New study reveals that mild glucose intolerance in pregnancy may relate to risk of heart disease

Mild glucose intolerance in pregnancy may be an early identifier of women who are at increased risk of heart disease in the future, found a new study http://www.cmaj.ca/press/cmaj090569.pdf published in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

25 Aug 2009

Research reveals the life-long detrimental impact of maternal smoking during pregnancy

A new study by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that the life-long effects of maternal smoking during pregnancy may occur through specific changes in DNA patterns.

25 Aug 2009

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).

25 Aug 2009

Emergency contraceptive tablet to help prevent an unintended pregnancy

There is good news for college students as they head back to campus this fall. A new emergency contraceptive, Plan B® One-Step (levonorgestrel) tablet, 1.5 mg, is now available at the local pharmacy for all students 17 and older.

24 Aug 2009

Mom & Baby mobile health centers serve pregnant women, teenagers and children

Four years after the hurricanes of 2005, four March of Dimes Mom & Baby Mobile Health Centers(R) serve as the primary health care providers for thousands of pregnant women, teenagers and children living along the Gulf Coast.

24 Aug 2009

Lundbeck to launch Sabril in the US following FDA's NDA approval

Lundbeck Inc. (“Lundbeck”), a wholly owned subsidiary of H. Lundbeck A/S in Denmark (Copenhagen: LUN), announced today that the U.S. Food and Drug Administration (FDA) has granted two New Drug Application (NDA) approvals for Sabril® (vigabatrin) Tablets and Oral Solution. Lundbeck plans to launch Sabril in the United States in the third quarter.

24 Aug 2009

MicroPhage's new platform for rapid identification of bacterial infections

MicroPhage announced today the launch of its multi-site clinical trial to support a U.S. Food and Drug Administration (FDA) premarket notification [510(k)]. The platform has been developed to rapidly identify bacterial infections and determine antibiotic susceptibility or resistance to aid physicians in antibiotic management.

21 Aug 2009

Expectant mothers cautioned against using home fetal Doppler devices

Mums-to-be are being advised not to use personal monitors (Doppler devices) to listen to their baby's heartbeat at home over fears that they may lead to delays in seeking help for reduced fetal movements.

21 Aug 2009

Coping with burn injuries

More than half a million Americans are treated for burn injuries every year, but many do not have the specific skills necessary to cope with the experience of living with a burn injury after they leave the hospital.

20 Aug 2009

National Institute on Drug Abuse funds study on development of prenatally cocaine-exposed children

Teen years are filled with experimenting. Sometimes that means trying some risky behaviors.

20 Aug 2009

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

20 Aug 2009

Arizona finalizes health care contract

CIGNA HealthCare announced today that it is one of four companies to have been awarded a contract to provide medical benefits to Arizona's state employees, university employees and retirees. The contract becomes effective October 1, 2009.

20 Aug 2009

IVF treatment not to be combined with alternative therapies

Women who are desperately trying to get pregnant might want to avoid complementary and alternative medicine. The common belief is that it won't hurt to try alternative fertility treatments before reverting to in vitro fertilization (IVF). But a new study from Denmark finds that the success of IVF treatment is 30% lower among women who have used alternative medicine.

19 Aug 2009

Genentech announces Phase III study results for Avastin (bevacizumab) in combination with chemo in HER2-negative breast cancer

Genentech, Inc. today announced that a Phase III study (RIBBON 2) of Avastin (bevacizumab) in combination with chemotherapy increased the time women with metastatic HER2-negative breast cancer whose initial chemotherapy had stopped working lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone.

18 Aug 2009

FDA approves Extavia for multiple sclerosis

The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.

17 Aug 2009

Mother's immune system may block fetal treatments for blood diseases

Pediatric researchers have resolved an apparent contradiction in the field of prenatal cell transplantation - a medical approach that holds future promise in correcting sickle cell disease and other serious congenital blood disorders. In a new study in animals, the researchers showed that the mother's immune response interferes with the offspring's earlier ability to tolerate transplanted donor cells.

17 Aug 2009

Seizures during pregnancy linked to pre-term, small or low-birth-weight babies

Women with epilepsy who have seizures during pregnancy appear more likely to give birth to pre-term, small or low-birth-weight babies than women without epilepsy, according to a report in the August issue of Archives of Neurology.

10 Aug 2009

Pregnancy News and Research

Latest Pregnancy News and Research

CP Family Network's guide helps parents find resouces for their children with Cerebral Palsy

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

Garden Of Life introduces dietary supplement capsule that minimizes varicose and spider veins

New study reveals that mild glucose intolerance in pregnancy may relate to risk of heart disease

Research reveals the life-long detrimental impact of maternal smoking during pregnancy

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Emergency contraceptive tablet to help prevent an unintended pregnancy

Mom & Baby mobile health centers serve pregnant women, teenagers and children

Lundbeck to launch Sabril in the US following FDA's NDA approval

MicroPhage's new platform for rapid identification of bacterial infections

Expectant mothers cautioned against using home fetal Doppler devices

Coping with burn injuries

National Institute on Drug Abuse funds study on development of prenatally cocaine-exposed children

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Arizona finalizes health care contract

IVF treatment not to be combined with alternative therapies

Genentech announces Phase III study results for Avastin (bevacizumab) in combination with chemo in HER2-negative breast cancer

FDA approves Extavia for multiple sclerosis

Mother's immune system may block fetal treatments for blood diseases

Seizures during pregnancy linked to pre-term, small or low-birth-weight babies

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Pregnancy News and Research

Latest Pregnancy News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in